HIVE vs OPEX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 30, 2026

HIVE

55.1
AI Score
VS
HIVE Wins

OPEX

36.0
AI Score

Investment Advisor Scores

HIVE

55score
Recommendation
HOLD

OPEX

36score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE OPEX Winner
Forward P/E 4.2699 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 285.3% 0.0% HIVE
Earnings Growth -99.9% 0.0% OPEX
Tradestie Score 55.1/100 36.0/100 HIVE
Profit Margin 17.8% 0.0% HIVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL HIVE

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.